| 中國文化大學 |
1996 |
Heptafulvenes之環外和環內取代基對其進行構研究Heptafulvenes in Heptafulvenes-Fulvenes(m+n)cloadditions
|
劉清揚 |
| 中國文化大學 |
1992 |
Heptafulvenes和6-Methyl-6-phenylfulvene分子間環化加成反應機構研究
|
陳信尹 |
| 中國文化大學 |
1992 |
Heptafulvenes和6-phenylfulvene分子間環化加成反應機構研究
|
游瓊誼 |
| 中國文化大學 |
1991 |
Heptafulvenes與Fulvenes分子間環化加成反應機構研究
|
丁順堂 |
| 大葉大學 |
2013-10 |
HER Catalytic Activity of Electrodeposited Ni-P Nanowires under the Influence of Magnetic Field
|
Lee, Hung-Bin;Tsau, Jiun-Chen;Lee, Chun-Ying |
| 國立臺灣海洋大學 |
2013-10 |
HER Catalytic Activity of Electrodeposited Ni-P Nanowires under the Influence of Magnetic Field
|
Hung-Bin Lee; Jiun-Chen Tsau; Chun-Ying Lee |
| 臺大學術典藏 |
2008 |
HER-2 antibody conjugated gold nano rod particles for in vivo photothermal therapy
|
PAI-CHI LI; Shieh, D.-B.; Ding, A.-A.;Chen, Y.-Y.;Churng-Wang, R.C.;Li, P.-C.;Shieh, D.-B.; Ding, A.-A.; Chen, Y.-Y.; Churng-Wang, R.C.; Li, P.-C. |
| 國立臺灣大學 |
2004 |
HER-2 siRNA造成HER-2大量表現癌細胞凋亡之研究
|
李幸芳; Lee, Hsin-Fang |
| 高雄醫學大學 |
2001 |
HER-2/neu (c-erb-B2) oncoprotein 在家族性及非家族性乳癌的表現
|
蔡坤寶;侯明鋒;林相如;蔡志仁;劉景勳;黃宗人 ; Kun-Bow Tsai;Ming-Feng Hou;Hsiang-Ju Lin;Chee-Yin Chai;Chiang-Shin Liu;Tsung-Jen Huang |
| 高雄醫學大學 |
2001 |
HER-2/neu Oncoprotein 在家族性及非家族性乳癌的表現
|
蔡坤寶;侯明鋒;林相如;蔡志仁;劉景勳;黃宗人 ; Kun-Bow Tsai;Ming-Feng Hou;Hsiang-Ju Lin;Chee-Yin Chai;Chiang-Shin Liu;Tsung-Jen Huang |
| 臺大學術典藏 |
2018-09-10T05:32:09Z |
HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors.
|
Huang, C.S. and Chen, Y.C. and Wang, M. and Lin, J.K. and Chang, K.J.; CHIUN-SHENG HUANG |
| 臺大學術典藏 |
2020-03-23T07:19:42Z |
HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors.
|
CHIUN-SHENG HUANG; Chen Y.C.; Wang M.; Lin J.K.; Chang K.J.; Chiun-Sheng Huang;Chen Y.C.;Wang M.;Lin J.K.;Chang K.J. |
| 臺大學術典藏 |
2022-08-12T06:29:13Z |
HER-2/neu overexpression in Chinese breast cancers: correlation with other prognostic factors.
|
Huang C.S.; Chen Y.C.; Wang M.; Lin J.K.; KING-JEN CHANG |
| 臺大學術典藏 |
2018-09-10T04:04:33Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Hsu, C.;Huang, C.-L.;Hsu, H.-C.;Lee, P.-H.;Wang, S.-J.;Cheng, A.-L.; PO-HUANG LEE; ANN-LII CHENG |
| 臺大學術典藏 |
2022-08-19T00:21:17Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Cheng A.-L.; Wang S.-J.; Lee P.-H.; Huang C.-L.; Hsu H.-C.; CHIUN HSU |
| 國立臺灣大學 |
2002 |
Her-2/Neu Overexpression Is Rare in Hepatocellular Carcinoma and Not Predictive of Anti-Her-2/Neu Regulation of Cell Growth and Chemosensitivity
|
許駿; 許輝吉; 鄭安理; HSU, CHIUN; HSU, HEY-CHI; CHENG, ANN-LII |
| 臺大學術典藏 |
2020-04-10T12:51:31Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Chiun Hsu;Huang C.-L.;Hsu H.-C.;Lee P.-H.;Wang S.-J.;Cheng A.-L.; Chiun Hsu; Huang C.-L.; Hsu H.-C.; Lee P.-H.; Wang S.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Hsu C.; Huang C.-L.; Hsu H.-C.; Lee P.-H.; Wang S.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2020-11-19T03:43:04Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Huang C.-L.; Hsu H.-C.; PO-HUANG LEE; Wang S.-J.; Cheng A.-L.; Hsu C.; Hsu C.;Huang C.-L.;Hsu H.-C.;Po-Huang Lee;Wang S.-J.;Cheng A.-L. |
| 國立成功大學 |
2007-04-27 |
HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer
|
Su, Wen-Pin; Tu, I-Hwi; Hu, Shiao-Wen; Yeh, Hsuan-Heng; Shieh, Dar-Bin; Chen, Tsai-Yun; Su, Wu-Chou |
| 國立成功大學 |
2006-02-24 |
HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion
|
Hsu, Ming-Chuan; Chang, Hui-Chiu; Hung, Wen-Chun |
| 國立中山大學 |
2006 |
HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion
|
M.C. Hsu;H.C. Chang;W.C. Hung |
| 國立成功大學 |
2007-09 |
HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells
|
Hsu, Ming-Chuan; Chang, Hui-Chiu; Hung, Wen-Chun |
| 國立中山大學 |
2007 |
HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells
|
M.C. Hsu;H.C. Chang;W.C. Hung |
| 高雄醫學大學 |
2001 |
Her-2/neu 腫瘤蛋白在家族性及非家族性乳癌的表現
|
蔡坤寶;侯明鋒;林相如;蔡志仁;劉景勳;黃宗人 ; Kun-Bow Tsai;Ming-Feng Hou;Hsiang-Ju Lin;Chee-Yin Chai;Chiang-Shin Liu;Tsung-Jen Huang |
| 中國醫藥大學 |
2011-07-31 |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討
|
黃偉謙(Wei-Chien Huang); 洪明奇(Mien-Chie Hung) |
| 中國醫藥大學 |
2010-07-31 |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討
|
黃偉謙(Wei-Chien Huang); 洪明奇(Mien-Chie Hung) |
| 中國醫藥大學 |
2009-07-31 |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討
|
黃偉謙(Wei-Chien Huang); 洪明奇(Mien-Chie Hung) |
| 嘉南藥理大學 |
2023 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
Chen, Chien-Chin; Chen, Helen H. W.; Lee, Chung-Ta; Lin, Peng-Chan; Chen, Shang-Hung; Lin, Bo-Wen; Chiu, Pin-Hsuan; Su, Pei-Fang; Chu, Chun-Ting; Yeh, Yu-Min; Chen, Po-Chuan |
| 國家衛生研究院 |
2023-03 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
Chen, PC;Yeh, YM;Chu, CT;Su, PF;Chiu, PH;Lin, BW;Chen, SH;Lin, PC;Lee, CT;Chen, HHW;Chen, CC |
| 國立成功大學 |
2023-3 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
葉裕民; YEH, YU-MIN; Chen, Po-Chuan;Yeh, Yu-Min;Chu, Chun-Ting;Su, Pei-Fang;Chiu, Pin-Hsuan;Lin, Bo-Wen;Chen, Shang-Hung;Lin, Peng-Chan;Lee, Chung-Ta;Chen, Helen H.W.;Chen, Chien-Chin |
| 國立成功大學 |
2023 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
Chen, P.-C.;Yeh, Yeh Y.-M.;Chu, Chu C.-T.;Su, P.-F.;Chiu, P.-H.;Lin, B.-W.;Chen, S.-H.;Lin, P.-C.;Lee, C.-T.;Chen, H.H.W.;Chen, Chen C.-C. |
| 臺大學術典藏 |
2022-04-14T23:27:49Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan, Ryan Shea Ying Cong; Ong, Whee Sze; Lee, Kyung Hun; Lim, Abner Herbert; Park, Seri; Park, Yeon Hee; CHING-HUNG LIN; YEN-SHEN LU; Ono, Makiko; Ueno, Takayuki; Naito, Yoichi; Onishi, Tatsuya; Lim, Geok Hoon; Tan, Su Ming; Lee, Han Byoel; Ryu, Han Suk; Han, Wonshik; Tan, Veronique Kiak Mien; Wong, Fuh Yong; Im, Seock Ah; Tan, Puay Hoon; Chan, Jason Yongsheng; Yap, Yoon Sim |
| 臺大學術典藏 |
2022-05-11T08:25:41Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN; Lu Y.-S.; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. |
| 中山醫學大學 |
2010 |
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
|
Han, CP; Hsu, JD; Yao, CC; Lee, MY; Ruan, A; Tyan, YS; Yang, SF; Chiang, H |
| 高雄醫學大學 |
2006 |
HER2 I655V 多形異化Val攜帶者基因型是台灣乳癌早發危險因子
|
侯明鋒;謝佩真;歐陽賦;陳芳銘;王照元;謝建勳;黃裕勝;黃哲人;黃宗人;侯孟君;侯乃文;蔡世盟;蔡麗玉 |
| 高雄醫學大學 |
2006 |
HER2 I655V 多形異化Val攜帶者基因型是台灣乳癌早發危險因子
|
侯明鋒;謝佩真;歐陽賦;陳芳銘;王照元;謝建勳;黃裕勝;黃哲人;黃宗人;侯孟君;侯乃文;蔡世盟;蔡麗玉 |
| 國家衛生研究院 |
2015-05 |
HER2 testing in breast cancer by quantitative PCR: Technical and clinical considerations
|
Yu, R;Chen, WC;Chiu, KY;Lu, S;Liu, YC;Ko, HY;Wu, HC;Hsieh, WC;Lee, ZJ;Zhang, P;Shi, LL;Liu, M;Chang, KC;Su, IJ;Su, P;Yeh, YM |
| 中國醫藥大學 |
2015-05-03 |
HER2 upregulates PD-L1 expression through PI3K-Akt pathway
|
施志諭(Chih-Yu Shih);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2019-08-23 |
HER2/EZH2/GOT2在乳癌細胞中調控腫瘤惡化之角色探討
|
葉屹倫;Yi-Lun Ye |
| 中山醫學大學 |
2015 |
HER2及其相關路徑在黏液性卵巢癌的相關研究
|
趙婉如; Chao, Wan-Ru |
| 國立臺灣大學 |
2006 |
HER2訊息途徑的活化調控雄性素受體功能與前列腺癌惡化關係之探討
|
何秉智; Ho, Ping-Chih |
| 中國醫藥大學 |
2014-12-31 |
HER2調控 EZH2 表現於乳癌發展之角色探討
|
黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2015-08-31 |
HER2調控乳癌細胞中PD-L1表現之探討
|
施志諭;Chih-Yu Shih |
| 國立成功大學 |
2023 |
HER2陽性抗性乳癌的治療探尋：小分子藥物組合與TROP2抗體藥物複合體
|
鍾為邦; 黃偉倫 |
| 國立高雄師範大學 |
2010-06-01 |
Heraclitus的認識論思想及其對現代認知科學的一些啟發
|
林財庫;方文宗;李鴻佑; Tsai-Ku Lin;Wen-Tsung Fang;Hung-Yu Li |
| 臺北醫學大學 |
2015-12 |
herb & hepatitis B
|
林辰翰 |
| 中國醫藥大學 |
2008-11-14 |
Herb extract with acetyl-CoA carboxylase inhibitory activity and its potential in treating metabolic syndrome
|
林毓舜; 張美瑜; 陳紀樺; 陳秀雯; 趙蓓敏(Pei-Min Chao); 趙蓓敏(Pei-Min Chao) |
| 國立臺灣大學 |
2016 |
Herb formula enhances treatment of impotent patients after penile venous stripping: a randomised clinical trials
|
Hsieh, C. -H.; Tsai, H. -C.; Hsu, G. -L.; Chen, C. -C.; Hsu, C. -Y. |
| 朝陽科技大學 |
2008-06-12 |
Herb-based Functional Foods: from Labboratories to the Market
|
張宏祺 |
